Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1967 1
1968 1
1969 1
1971 2
1977 2
1978 1
1980 2
1981 4
1982 9
1983 5
1984 7
1985 6
1986 9
1987 28
1988 45
1989 41
1990 45
1991 58
1992 89
1993 94
1994 97
1995 135
1996 101
1997 128
1998 134
1999 158
2000 167
2001 192
2002 208
2003 211
2004 254
2005 257
2006 244
2007 297
2008 301
2009 323
2010 353
2011 388
2012 375
2013 340
2014 311
2015 330
2016 255
2017 252
2018 253
2019 268
2020 94
Text availability
Article attribute
Article type
Publication date

Search Results

6,333 results
Results by year
Filters applied: . Clear all
Page 1
Folate and epigenetics: why we should not forget bacterial biosynthesis.
Kok DE, Steegenga WT, McKay JA. Kok DE, et al. Epigenomics. 2018 Sep;10(9):1147-1150. doi: 10.2217/epi-2018-0117. Epigenomics. 2018. PMID: 30238776 Free article. No abstract available.
[A Case of Recurrent Hyperammonemic Encephalopathy during Adjuvant Chemotherapy(Modified FOLFOX6)for Colorectal Cancer].
Yoshino Y, Tamura A, Kagami S, Funahashi K. Yoshino Y, et al. Gan To Kagaku Ryoho. 2018 Nov;45(11):1665-1668. Gan To Kagaku Ryoho. 2018. PMID: 30449860 Review. Japanese.
A 60-year-old woman was administered mFOLFOX6 therapy as postoperative adjuvant chemotherapy for fStage III a ascending colon cancer. The patient developed a disorder of consciousness(Japan Coma Scale[JCS]III-200)immediately after the completion of the therapy. ...H …
A 60-year-old woman was administered mFOLFOX6 therapy as postoperative adjuvant chemotherapy for fStage III a ascending colon canc
Adjuvant chemotherapy for colon cancer.
Ducreux M, Boige V. Ducreux M, et al. Best Pract Res Clin Gastroenterol. 2002 Apr;16(2):283-98. doi: 10.1053/bega.2002.0287. Best Pract Res Clin Gastroenterol. 2002. PMID: 11969239 Review.
Colorectal cancer is one of the most frequent cancers in the world, especially in occidental countries. ...Combining levamisole with 5FU/leucovorin does not improve efficacy. In patients with stage II colon cancer it is still unclear whether adjuvant c
Colorectal cancer is one of the most frequent cancers in the world, especially in occidental countries. ...Combining levamisol
Adjuvant therapy for colorectal cancer in 2020: has anything changed this millennium?
Bridgewater J. Bridgewater J. Ann Oncol. 2020 Apr;31(4):447-448. doi: 10.1016/j.annonc.2020.01.015. Epub 2020 Feb 21. Ann Oncol. 2020. PMID: 32093918 No abstract available.
Folic acid supplementation and cancer risk: point.
Kim YI. Kim YI. Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2220-5. doi: 10.1158/1055-9965.EPI-07-2557. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18768486 Free article. Review. No abstract available.
New treatments for colon cancer.
Slevin M, Payne S. Slevin M, et al. BMJ. 2004 Jul 17;329(7458):124-6. doi: 10.1136/bmj.329.7458.124. BMJ. 2004. PMID: 15258046 Free PMC article. No abstract available.
Prognostic factors of overall survival for patients with stage II colon cancer.
Trivedi H, Chamarthy U, Dicarlo L, Herman J, Srkalovic G. Trivedi H, et al. Acta Med Acad. 2014;43(2):134-43. doi: 10.5644/ama2006-124.112. Acta Med Acad. 2014. PMID: 25529518 Free article.
OBJECTIVE: To analyze factors influencing survival of patients with stage II colon cancer treated at our cancer center (Sparrow Hospital) from February 1996 through December 2006. ...CONCLUSION: In this study we found that the most important factor for surviv …
OBJECTIVE: To analyze factors influencing survival of patients with stage II colon cancer treated at our cancer center …
Colon cancer in Chile.
Bower C, Milne E. Bower C, et al. Eur J Gastroenterol Hepatol. 2010 Jul;22(7):900. doi: 10.1097/MEG.0b013e32832e9d7d. Eur J Gastroenterol Hepatol. 2010. PMID: 20535077 No abstract available.
[Progression of adjuvant chemotherapy for colon cancer].
He YJ, Dong QM, Li YH. He YJ, et al. Ai Zheng. 2005 Dec;24(12):1546-9. Ai Zheng. 2005. PMID: 16351811 Free article. Review. Chinese.
The survival benefit of postoperative adjuvant chemotherapy for stage II colon cancer is controversial now; while postoperative adjuvant chemotherapy for high-risk colon cancer patients should be considered. The progression of postoperative adjuvant ch …
The survival benefit of postoperative adjuvant chemotherapy for stage II colon cancer is controversial now; while postoperativ …
Adjuvant therapy for stage II colon cancer: an elephant in the living room?
Zaniboni A, Labianca R; Gruppo Italiano per lo Studio e la Cura dei Tumori del Digerente. Zaniboni A, et al. Ann Oncol. 2004 Sep;15(9):1310-8. doi: 10.1093/annonc/mdh342. Ann Oncol. 2004. PMID: 15319235 Free article. Review.
At present, standard adjuvant treatment for patients with stage III colon cancer after surgical resection is represented by 6 months of chemotherapy based on 5-fluorouracil/leucovorin regimens. ...More questionable is the role of adjuvant chemotherapy for stage II …
At present, standard adjuvant treatment for patients with stage III colon cancer after surgical resection is represented by 6 …
6,333 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback